Exploring the Latest Developments: Proactive Investors Unveils New Milestone for Company with Ticker 1067100
Lisata Therapeutics: A Data-Rich Year Ahead In a recent statement accompanying its full-year 2024 financial results, Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazza shared his optimism about the future of the pharmaceutical company. Mazza expressed his belief that 2025 would be a “data-rich year” for Lisata, as the company continues to make strides in its…